ZelosDx logo — We develop blood testing products to help researchers make b...

ZelosDx

We develop blood testing products to help researchers make breakthrough discoveries in brain health and disease.

Founded 2010 United States Tucson, United States 7 employees Grant Total: $2.23M Biotechnology, Health Care +1

General Information

Company Name ZelosDx
Founded Year 2010
Location United States Tucson, United States
Employees 7
Industries Biotechnology, Health Care, Life Sciences
Funding Stage Grant
Social

BounceWatch is an independent company data service, not affiliated with ZelosDx. To contact ZelosDx, visit zelosdx.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does ZelosDx compare?

A PDF of ZelosDx and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting ZelosDx soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About ZelosDx

ZelosDx is a biotechnology and healthcare startup based in the United States, founded in 2010. The company's slogan, "We develop blood testing products to help researchers make breakthrough discoveries in brain health and disease," encapsulates their core mission. ZelosDx, formerly known as MSDx, Inc., specializes in creating blood testing products tailored to researchers in the field of brain health and disease. The company is actively seeking research collaborators to license and adapt their proprietary technology for blood testing kits and automated laboratory equipment. Additionally, they are looking for pharmaceutical collaborators interested in leveraging their biomarker technology for drug discovery tools to be used as endpoints in clinical trials related to neurodegenerative markets. The latest investment of $255.76K came in the form of a grant investment, which was secured on 12 August 2021 and was provided by the National Science Foundation. ZelosDx's strategic focus on advancing research and innovation in the critical area of brain health and disease positions them as an attractive prospect for potential investors and collaborators.

Business keywords: neurodegenerative diseases, brain health, blood testing products, research collaborators, proprietary technology, biomarker technology, drug discovery, clinical trials, pharmaceutical, laboratory equipment, licensing, partnerships, endpoint technologies

Funding Rounds & Investors (6)

View All
Funding Stage Amount Investors Lead Investors Date
Grant $255.76K 1
National Science Foundation
12 Aug 2021
Angel Round $200.00K 1
Desert Angels
11 Dec 2018
Seed Round $702.00K 4
Pipeline Angels, Desert Angels +2
01 Feb 2016
Grant $250.00K 1
The Michael J. Fox Foundation for Parkinson's Research
01 May 2013
Seed Round $573.00K 1
Desert Angels
01 Apr 2012
Grant $246.00K -
01 Mar 2011

ZelosDx Alternatives & Competitors

View All Alternatives
ZelosDx vs
Cerevance
Cerevance United States

Cerevance a neuroscience company

Series C
35 employees
Biotechnology, Health and Wellness
ZelosDx vs

Merck develops and produces medicines, vaccines, biologic therapies and animal health products

IPO
92 employees
Biotechnology, Health Care
ZelosDx vs

Treventis | TREVENTIS™ Corporation is an early stage biotechnology company focused on diseases assoc...

Seed
19 employees
Biotechnology, Health Care

FAQ About ZelosDx

We develop blood testing products to help researchers make breakthrough discoveries in brain health and disease.
ZelosDx was founded in 2010.
ZelosDx is headquartered in Tucson, United States.
ZelosDx operates in Biotechnology, Health Care and Life Sciences. Its work centres on neurodegenerative diseases, brain health, blood testing products and research collaborators.
ZelosDx has approximately 7 employees.
ZelosDx has completed 6 funding rounds, raising a total of $2.23M. The latest funding stage is Grant.
Top alternatives and competitors to ZelosDx include Cerevance, Merck & Co., Inc., Treventis Corporation, SPARK Neuro, RogCon, Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
ZelosDx and Cerevance are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for ZelosDx, https://bouncewatch.com/company/zelosdx, updated 14 November 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes